Skip to content

OPU-LUX: Virtual Reality for Pain and Anxiety Management During Oocyte Pick-up

OPU-LUX: Virtual Reality for Pain and Anxiety Management During Oocyte Pick-up - a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05830513
Acronym
OPU-LUX
Enrollment
100
Registered
2023-04-26
Start date
2023-05-31
Completion date
2025-05-31
Last updated
2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVF, Pain, Postoperative

Brief summary

In vitro fertilization (IVF) cycles are increasingly performed worldwide. Transvaginal oocyte pick-up (OPU) is a painful part of IVF. OPU in polyfollicular IVF is usually performed under sedation and pain relief. In natural cycle IVF or IVF with minimal stimulation OPU is possible without anesthesia. Mostly of the women reported experiencing mild to moderate pain when undergoing OPU without anesthesia. Nevertheless, there is a need for alternative pain treatment options during OPU to reduce the burden of IVF for patients. Virtual reality (VR) may have a role in acutely painful procedures as a non-pharmacological alternative. VR refers to the interactions between an individual and a computer-generated environment stimulating multiple sensory modalities. The immersive, entertaining effects of VR could be useful for redirecting the patient's attention away from painful treatment experiences and reducing anxiety, discomfort, or unpleasantness. Use of VR interventions has been studies in a wider range of medical treatment.

Interventions

DEVICEVirtual Reality

Women will be randomly allocated to undergo OPU either with the use of virutal reality (group A) or the control group with standard treatment, without analgesia(group B). The participants of group A will wear the Oculus Quest 2 and will be surrounded by a virtual world. They will see objects flying towards themselves. They will be able to interact with the virtual world by hand controllers and can try to catch the objects.

Sponsors

Luzerner Kantonsspital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 43 years * IVF with follicular aspiration of one to tree follicles * Written informed consent signed by the participant must be obtained prior to OPU

Exclusion criteria

* OPU with more than tree follicular aspiration * Individuals' anatomy complicating the intervention (e. g. endometriosis stage III/IV) * Application of analgesics within eight hours before OPU * hearing impairments * migraines * seizure disorder * vestibular abnormalities * history of motion sickness

Design outcomes

Primary

MeasureTime frameDescription
VASpost OPU (line from 0: no pain to 10:worst pain) immediately post OPUvisual analogue scale pain scoring

Secondary

MeasureTime frameDescription
VAS for anxietyPre-post OPU (line from 0: no to 10:worst anxiety) pre- und immediately post OPUVAS for anxiety
state-trait anxiety inventory form (STAI)Pre-OPUstate-trait anxiety inventory form (STAI)
vital parameters: pulse rateIntraoperativevital parameters : pulse rate
vital parameters: blood pressureIntraoperativevital parameters: blood pressure (systolic and diastolic pressures)
vital parameters : oxygen saturationIntraoperativevital parameters : oxygen saturation

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026